Why It’s Interesting, What to Consider, and Why Support Still Matters » Hangry Woman®
Awiqli, the first FDA-approved once-weekly basal insulin for adults with type 2 diabetes, could change how some people approach insulin therapy. Here’s what makes it interesting, the pros and cons…